Information Provided By: 
Fly News Breaks for April 20, 2017
ABT
Apr 20, 2017 | 07:54 EDT
RBC Capital analyst Glenn Novarro says that Abbott's Q1 results represented a "solid beat" and should ease concerns over the risks posed by its integration of St. Jude and its China nutritional business. The analyst keeps a $50 price target and an Outperform rating on the stock.
News For ABT From the Last 2 Days
There are no results for your query ABT
